Emily Rollins
Director at Dolby Laboratories, Inc. (DLB); Director at Xometry, Inc. (XMTR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $654K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 21SEC | XMTRXometry, Inc. | Sell Plan | 2,54017,596 held (−13%) | $83.61 | $212K | +32.8% |
| Aug 21SEC | XMTRXometry, Inc. | Sell Plan | 1,69215,904 held (−10%) | $84.83 | $144K | +30.9% |
| Aug 21SEC | XMTRXometry, Inc. | Sell Plan | 76815,136 held (−5%) | $85.47 | $66K | +30.0% |
| Apr 3SEC | DLBDolby Laboratories, Inc. | Sell Plan | 1,00012,541 held (−7%) | $60.08 | $60K | -2.2% |
| Apr 3SEC | XMTRXometry, Inc. | Sell Plan | 1,00015,136 held (−6%) | $42.02 | $42K | +164.3% |
| Jan 6SEC | XMTRXometry, Inc. | Sell Plan | 27512,180 held (−2%) | $60.90 | $17K | +82.4% |
| Jan 6SEC | XMTRXometry, Inc. | Sell Plan | 72511,455 held (−6%) | $62.23 | $45K | +78.5% |
| Nov 12SEC | XMTRXometry, Inc. | Sell Plan | 10612,349 held (−1%) | $66.16 | $7K | +67.9% |
| Nov 12SEC | XMTRXometry, Inc. | Sell Plan | 18612,163 held (−2%) | $67.16 | $12K | +65.4% |
| Nov 12SEC | XMTRXometry, Inc. | Sell Plan | 70811,455 held (−6%) | $68.53 | $49K | +62.1% |
- Sell
Director Emily Rollins sold $212K of XMTR at $83.61 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Emily Rollins sold $144K of XMTR at $84.83 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Emily Rollins sold $66K of XMTR at $85.47 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Emily Rollins sold $60K of DLB at $60.08 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Emily Rollins sold $42K of XMTR at $42.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Emily Rollins sold $17K of XMTR at $60.90 — pre-scheduled 10b5-1 plan sale.